Pharmacy Times briefs pharmacists on shifting peptide compounding rules
The trade publication frames peptide preparation as a fast-moving area where sourcing and regulatory status are changing for compounding pharmacists.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 10:42 ETSource: Pharmacy Times
The wire
- 01Pharmacy Times published guidance aimed at pharmacists on how peptide compounding practice is evolving and what they need to know now.
- 02Compounders and 503A/503B operators face ongoing questions about which peptides may lawfully be compounded and how to document bulk substance sourcing.
- 03The item is educational commentary rather than a new agency action; readers should check FDA category lists and state board positions for binding rules.
From the source
Read at pharmacytimes.comPeptide Compounding Is Evolving: What Pharmacists Need to Know Now
